Jim C. Hu, M.D., MPH

Dr. Jim Hu is a urologic oncologist with his undergraduate degree in Economics, his Master’s in Public Health in Health Policy and Management from Johns Hopkins University, and his Medical Degree from Baylor College of Medicine. He completed his Urology Residency at the David Geffen School of Medicine at UCLA and his Robotic Surgery/Urologic Oncology Fellowship in 2004 at City of Hope National Medical Center.

He began his career as the Director of Robotic and Minimally Invasive Surgery at Brigham and Women's Hospital and Instructor at Harvard Medical School and was quickly promoted to Director of the Prostate Cancer Program at Dana Farber/Harvard Cancer Center and Associate Professor. He was then recruited back to the David Geffen School of Medicine at UCLA as the Henry Singleton Chair of Robotic and Minimally Invasive Surgery, where he led the minimally invasive prostate cancer, kidney cancer, and kidney donor nephrectomy programs. He was promoted to Professor before joining the faculty at Weill Cornell Medical College in 2015 as the Director of the LeFrak Center for Robotic Surgery and the Ronald P. Lynch Chair in Urologic Oncology. He currently serves as the Vice-Chair of Clinical Research, Chair of Quality and Patient Safety, and the Course Director for Urology Grand Rounds.

Dr. Hu is an internationally renowned surgical innovator and health services researcher. His comparative effectiveness research interests have been funded by the Department of Defense, the National Cancer Institute, and the Livestrong Foundation. He is currently the contact principal investigator on two National Cancer Institute R0-1 randomized clinical trials investigating novel, potentially practice-changing approaches to prostate biopsy and radical prostatectomy. He is also the contact principal investigator on two Patient-Centered Outcomes Research Institute (PCORI) awards investigating prostate biopsy and comparative effectiveness of focal therapy, stereotactic body radiation therapy vs. conventional prostate cancer therapies. He has been awarded more than $12 million in peer-reviewed funding, and he has authored more than 300 peer-reviewed papers. His discoveries have been published in the most prestigious and exclusive medical journals, such as the New England Journal of Medicine, the Journal of the American Medical Association, and the Journal of Clinical Oncology, as well as featured in the New York Times, Wall Street Journal, and Boston Globe. In addition, Dr. Hu has published the most advances/videos of technical modifications internationally in European Urology Surgery in Motion to improve prostate and kidney cancer surgical outcomes. Dr. Hu has performed over 4000 laparoscopic, robotic and open procedures.

Testimonial:

"Dr Hu performed a radical prostatectomy on me after a diagnosis of cancer. In consultations with me prior to surgery, he was warm and kind, and extremely informative. He showed great patience, answered all of my questions, met with my wife, and left me feeling that I had made a fully-informed decision. And then the real skills shine through - Dr. Hu's surgical abilities left me with truly minimal side effects. I was walking within hours after surgery and my overall recovery has been swift." - Michael L.

"Dr. Hu performed a robotic radical prostatectomy. Long and short term outcomes were better than I anticipated. Only missed 7 days of work. He is a highly competent surgeon, a great doctor and a truly nice person. I highly recommend Dr. Hu." - John M.

“Dr. Hu listened when others wrote my symptoms as benign . He resolved all my issues and I am thankful for his skills.” - Francis M. via. Google

"Dr. Hu was the most considerate, compassionate and on top of things during my robotic surgery (pre and post op), He took the time to share details and explained everything to me and my husband thoroughly." - Timothy B. via Google 

"The Weill Cornell experience was top shelf from start to finish and Dr. Hu is a rock star robotic surgeon who knows how to communicate with his patients." - Richard F. via Google

"He patiently answered all our questions, and made himself available via phone and email in a very responsive manner. The surgery went as I expected, and the results have been outstanding. My recovery was easier than I expected and I have experienced none of the possible negative side-effects of this surgery. I did not have any incontinence at all and other expected issues have resolved themselves. I can't recommend Dr. Hu and his staff more highly. I attribute my successful outcome to early detection (get your checkups!) and Dr. Hu's skill and expertise." - John V. via Google

" A master and true professional. Dr. Hu and his team are a miracle to me. Honest, caring, to the point, professional, comforting...; and the result says all. Still in the middle of recovery, but so far, all beyond expectations. I have been in the best hands. Very thankful." - Self-verified patient on April 16, 2019 via Vitals

"Dr. Hu and his team are exceptional healthcare providers. I felt 100% confident that I was receiving the best care possible, from diagnosis, healthcare options, to pre and post surgery care, Dr. Hu and his team were amazing!" - Self-verified patient on August 20, 2018 via Vitals 

"Dr. Hu was the surgeon for my prostate cancer. I couldn’t be happier with my results. Way ahead of schedule in my recovery." - Terence G. via Healthgrades on May 14, 2018

His work and expertise has been sought by national news outlets such as the New York Times, Wall Street Journal, Mens Health and others. 

Some of these may be found below:

• Overuse of Prostate Cancer Scans May Be Easing (Renal & Urology News)
• The federal panel that opposed prostate cancer screening just changed its mind (Washington Post)
• Diagnosed with Prostate Cancer? 4 Big Mistakes Men Are Making
• Active surveillance, physician–patient communication may redefine role of PSA testing (Healio)
• ASCO GU 2017: Best of Journals Prostate Cancer: Urology View - Session Highlights
• Incidence of Metastatic Prostate Cancer in Older Men Increases Following Drop in PSA Screening
• Increase in Prostate Cancer Distant Metastases at Diagnosis in the United States (JAMA Oncology)
• More Advanced Prostate Cancer Seen in Older US Men (MedScape)
• Making Decisions About New Cancer Treatments With Limited Evidence (Journal of Clinical Pathways)
• Infections After Prostate Biopsy Continue to Rise
• Prostate Surgery Rates Fall After Screening Advice, Study Finds (NBC News)
• For Partial Nephrectomy Outcomes, Robot Bests Laparoscopy (Medscape)
• National Prostate Biopsy and Radical Prostatectomy Volumes Decreased Significantly Following Recommendation against PSA Screening
• Results Unproven, Robotic Surgery Wins Converts (New York Times)
• Surgical Robot Fails to Show Advantages in Treating Bladder Cancer (Wall Street Journal)
• Prostate Cancer: No Survival Hit With Surveillance (MedPage Today)
• Robot Surgery is Here to Stay (The Bulletin)
• Almost all men with early prostate cancer survive 10 years, regardless of treatment (Washington Post)
• Robotic Surgery Expert Joins NewYork-Presbyterian Hospital and Weill Cornell Medical College
• Find An Experienced, Gentle Surgeon (Science Daily)
• Most commonly used treatment for prostate cancer is radiotherapy (Oncology Nurse Advisor)
• Do Robots Drive Up Prostate Surgeries? (Fox News)
• Master of the Robot (Middle East Health Magazine)
• Robotic Surgeons Take Over at a Hospital Near You (Popular Mechanics)
• KCLU's Lance Orozco Reports Firsthand About Battling Kidney Cancer

If you would like to make an appointment with Dr. Hu, please call his office at (646) 962-9600. You may view his accepted insurances on his profile at urology.weillcornell.org.  

Dr. Hu's office is located in the LeFrak Center for Robotic Surgery at 525 E. 68th Street, 9th floor, Starr 946.